Business Description
Spago Nanomedical AB
ISIN : SE0004899474
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.83 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 3.54 | |||||
Beneish M-Score | -1.56 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 152 | |||||
3-Year EBITDA Growth Rate | 12.6 | |||||
3-Year EPS without NRI Growth Rate | 14.9 | |||||
3-Year FCF Growth Rate | 28.7 | |||||
3-Year Book Growth Rate | -29.2 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.04 | |||||
9-Day RSI | 41.66 | |||||
14-Day RSI | 45.3 | |||||
6-1 Month Momentum % | 3.86 | |||||
12-1 Month Momentum % | -61.52 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.83 | |||||
Quick Ratio | 5.83 | |||||
Cash Ratio | 4.65 | |||||
Days Sales Outstanding | 73.5 | |||||
Days Payable | 136.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -59.3 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -1052.11 | |||||
Operating Margin % | -3194.69 | |||||
Net Margin % | -3094.15 | |||||
FCF Margin % | -3690.48 | |||||
ROE % | -16.25 | |||||
ROA % | -15.58 | |||||
ROIC % | -21.2 | |||||
ROC (Joel Greenblatt) % | -2937.88 | |||||
ROCE % | -16.77 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 59.8 | |||||
PB Ratio | 1.95 | |||||
Price-to-Tangible-Book | 1.99 | |||||
EV-to-EBIT | -1.49 | |||||
EV-to-Forward-EBIT | -0.85 | |||||
EV-to-EBITDA | -1.5 | |||||
EV-to-Forward-EBITDA | -0.85 | |||||
EV-to-Revenue | 47.54 | |||||
EV-to-Forward-Revenue | 3.27 | |||||
EV-to-FCF | -1.29 | |||||
Price-to-Net-Current-Asset-Value | 1.99 | |||||
Price-to-Net-Cash | 2.72 | |||||
Earnings Yield (Greenblatt) % | -67.11 | |||||
FCF Yield % | -40.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Spago Nanomedical AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 0.735 | ||
EPS (TTM) (kr) | -0.192 | ||
Beta | 0.15 | ||
Volatility % | 58.73 | ||
14-Day RSI | 45.3 | ||
14-Day ATR (kr) | 0.031257 | ||
20-Day SMA (kr) | 0.32095 | ||
12-1 Month Momentum % | -61.52 | ||
52-Week Range (kr) | 0.195801 - 0.859615 | ||
Shares Outstanding (Mil) | 224.72 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Spago Nanomedical AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Spago Nanomedical AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Spago Nanomedical AB Frequently Asked Questions
What is Spago Nanomedical AB(OSTO:SPAGO)'s stock price today?
When is next earnings date of Spago Nanomedical AB(OSTO:SPAGO)?
Does Spago Nanomedical AB(OSTO:SPAGO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |